Remarkably, the AUC values, specificity and sensitivity analyzed for ΔNp73, Δ133p53 and CEA support the levels of CEA in plasma as a better marker of patients with advanced CRC than ΔNp73 and Δ133p53 content in EVs. This evidence concerns the gene CEACAM5 and colorectal carcinoma.